# TSI and Its Relationship With Graves' Disease Relapse

> **NCT05713097** · — · COMPLETED · sponsor: **University of Medicine and Pharmacy at Ho Chi Minh City** · enrollment: 352 (actual)

## Conditions studied

- Graves Disease
- Immunoglobulin
- Anti-Thyroid Antibodies Disorder

## Interventions

- **DIAGNOSTIC_TEST:** TSI

## Key facts

- **NCT ID:** NCT05713097
- **Lead sponsor:** University of Medicine and Pharmacy at Ho Chi Minh City
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-02
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 352 (ACTUAL)
- **Last updated:** 2023-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05713097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05713097, "TSI and Its Relationship With Graves' Disease Relapse". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05713097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*